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THE EFFECTS OF A FREE FATTY ACID PREPARATION OF OMEGA-3 
POLYUNSATURATED FATTY ACIDS ON PLATELET FUNCTION ALONE 
AND IN COMBINATION WITH ASPIRIN AND LOW MOLECULAR WEIGHT 
HEPARIN. 
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Prior to performing a trial using Omega-3 Polyunsaturated 
Fatty Acids (PUFA) and/or low Molecular Weight Heparin 
(LMWH) in the prevention of PTCA restenosis, we examined 
the effects of.PUFA, aspirin (ASA), and LMWH on bleeding 
time (8T) and other measures of olateie? function. Ten 
subjects consumed 7.4 g/d of PUFF administered as a free 
fatty acid (FFA) for 21 davs. ASA (325 ma) was adminis- 
tered on day 7 and also on-day 21 in combination with 
30 mg SC of LMWH. Significant platelet membrane incorpora- 
tion of eicosapentaenoic (EP,,) and docosahexaenoic (DHA) 
acids was seen at 48 hrs (~4.01) and continued to rise to 
day 21 (p<.OOl) along with an associated fall ( 01) in 
platelet arachidonate. PUFA had no inhibitory effect on 
1) BT (baseline 3.8 + 0.4 min vs. day 21 3.9 min t 4.0 
min), 2) platelet ag$+egation (in respcnse to ADP-and 
collagen) and 3) platelet adhesion to a cultured endothe- 
lial cell monolayer. BT prolongation occurred with PUFAt 
ASA (1.9X baseline, p(.OOl) and PUFA+ASA+LMWH (2.2X base- 
line, p<.OOl), but there was no evidence to suggest that 
PUFA or LMWH enhanced the effect of ASA on BT. The moan 
8T with the combination of PUFAtASA+LMWH was 8.1 + 0.9 min. 
Despite the demonstration of early incorporation of EPA 
and DHA into platelet membranes using a FFA preparation of 
PUFA, we were unable to demonstrate an inhibitory effect 
on platelet function. Furthermore PUFA combined with AS:, 
and LMWH does not p-oionc bleeding times beyond that seen 
with ASA alone. 
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